Canakinumab
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Product Specifications
CAS Number
914613-48-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2923977-01 20 µg
Recombinant Bacillus cereus Cardiolipin synthase 2 (cls2)
Sign In for Pricing
View Details orb2923977-02 100 µg
Recombinant Bacillus cereus Cardiolipin synthase 2 (cls2)
Sign In for Pricing
View Details 